Oct 27, 2026 04:33PM
Oct 6, 2026 08:06AM
Sep 29, 2026 03:30AM
Sep 17, 2026 08:32AM
Sep 17, 2026 07:46AM
Sep 15, 2026 06:32AM
Sep 15, 2026 06:30AM Telo Genomics Announces Clinical Research Results Evidencing Utility of Its Telomere Analysis Platform in Predicting Multiple Myeloma Relapse
Aug 10, 2026 08:03AM
Jun 15, 2026 08:01AM
Jun 15, 2026 08:00AM
May 20, 2026 08:00AM
Apr 30, 2026 08:50AM
Apr 30, 2026 08:00AM
Apr 24, 2026 09:00AM Telomir Pharmaceuticals completes TELI acquisition for global drug rights
Apr 24, 2026 09:00AM
Mar 31, 2026 08:06AM
Mar 31, 2026 08:00AM
Feb 17, 2026 08:00AM
Feb 5, 2026 08:05AM
Feb 5, 2026 08:00AM
Jan 13, 2026 07:20AM Rodman & Renshaw Starts Telomir Pharma (TELO) at Buy
Jan 5, 2026 08:03AM
Jan 5, 2026 08:00AM
Dec 18, 2025 07:30AM
Dec 17, 2025 04:03PM
Nov 25, 2025 08:02AM
Nov 25, 2025 08:00AM
Nov 21, 2025 07:30AM Telomir reports drug candidate shows activity against leukemia cells
Nov 21, 2025 07:30AM
Nov 12, 2025 08:01AM
Nov 12, 2025 08:00AM
Oct 23, 2025 07:30AM
Oct 23, 2025 07:30AM
Oct 21, 2025 07:32AM
Oct 21, 2025 07:30AM Telomir Pharmaceuticals Executes Binding LOI for Worldwide Rights to Telomir-1, Positioning the Company for Global Market Expansion and Value Growth
Oct 14, 2025 08:02AM
Oct 14, 2025 08:00AM
Oct 9, 2025 07:31AM
Oct 9, 2025 07:30AM
Oct 7, 2025 07:30AM
Oct 7, 2025 07:30AM
Oct 6, 2025 04:05PM Telomir Pharmaceuticals reports preclinical cancer findings
Sep 18, 2025 08:00AM
Sep 9, 2025 08:13AM
Sep 9, 2025 08:00AM
Aug 28, 2025 08:00AM
Aug 28, 2025 08:00AM
Aug 7, 2025 08:00AM
Aug 7, 2025 08:00AM Telomir Pharmaceuticals Announces In Vitro Data Showing Telomir-1 Inhibits Key Epigenetic Enzymes Driving Tumor Growth, Autoimmune Disease, Neurodegeneration, and Metabolic Dysfunction
Jul 24, 2025 08:01AM

485,022 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All